Financial Performance in January-December 2022
| Consolidated statement of comprehensive income, MEUR | 2022 | 2021 |
| 12 months | 12 months | |
| Net sales | 82.5 | 86.9 |
| Operating profit / loss | 0.3 | 3.2 |
| Financial income and expenses | -0.8 | -0.7 |
| Result before tax | -0.4 | 2.5 |
| Result for the period | 0.3 | 3.3 |
| Total comprehensive income for the period | 0.5 | 3.6 |
| Result for the period attributable to: | ||
| Equity holders of the parent | 0.3 | 3.3 |
| Total comprehensive income for the period attributable to: | ||
| Equity holders of the parent | 0.5 | 3.6 |
| Earnings per share from continuing operations, EUR | 0.007 | 0.093 |
Half Year Figures
| Group's net sales and operating result, MEUR | 2H/22 | 1H/22 | 2H/21 | 1H/21 |
| Net sales | 41.4 | 41.0 | 47.2 | 39.7 |
| Operating profit (loss) | 0.6 | -0.2 | 3.9 | -0.7 |
| Result before taxes | 0.2 | -0.7 | 3.6 | -1.0 |
| Result for the period | 0.9 | -0.6 | 4.4 | -1.0 |
| Distribution of net sales by product and services, MEUR and % | 2H/22 | 1H/22 | 2H/21 | 1H/21 |
| Product based netsales | 30.2 72.9% |
27.2 66.3% |
35.2 74.5% |
27.9 70.3% |
| Services based net sales | 11.2 27.1% |
13.8 33.7% |
12.0 25.5% |
11.8 29.7% |
| Distribution of product-based net sales, MEUR and % | 2H/22 | 1H/22 | 2H/21 | 1H/21 |
| Defense & Security products | 18.9 62.6% |
15.9 58.5% |
20.8 59.3% |
14.5 51.8% |
| Medical Technologies products | 11.3 37.4% |
11.3 41.5% |
14.3 40.7% |
13.5 48.2% |
| Distribution of services-based net sales, MEUR and % | 2H/22 | 1H/22 | 2H/21 | 1H/21 |
| Connectivity Solutions R&D services | 7.2 64.0% |
8.0 57.8% |
7.7 63.8% |
7.8 66.6% |
| Other service-based net sales | 4.0 36.0% |
5.8 42.2% |
4.4 36.2% |
3.9 33.4% |
| Distribution of net sales by market areas, MEUR and % | 2H/22 | 1H/22 | 2H/21 | 1/21 |
| Asia | 0.7 1.8% |
0.5 1.3% |
0.3 0.6% |
0.3 0.6% |
| North and South America | 12.9 31.1% |
10.4 25.4% |
14.9 31.5% |
14.4 36.4% |
| Europe | 27.8 67.1% |
30.1 73.3% |
32.0 67.9% |
25.0 62.9% |
Quarterly Figures
| Group's net sales and operating result, MEUR | 4Q/22 | 3Q/22 | 2Q/22 | 1Q/22 | 4Q/21 |
| Net sales | 27.6 | 13.8 | 22.7 | 18.4 | 30.1 |
| Operating profit (loss) | 3.0 | -2.4 | 0.8 | -1.0 | 3.7 |
| Result before taxes | 2.8 | -2.6 | 0.6 | -1.2 | 3.5 |
| Result for the period | 3.5 | -2.6 | 0.6 | -1.2 | 4.3 |
| Distribution of net sales by product and services, MEUR and % | 4Q/22 | 3Q/22 | 2Q/22 | 1Q/22 | 4Q/21 |
| Product based net sales | 20.9 75.8% |
9.3 67.3% |
15.8 69.7% |
11.4 62.0% |
23.0 76.5% |
| Services based net sales | 6.7 24.2% |
4.5 32.7% |
6.9 30.3% |
7.0 38.0% |
7.1 23.5% |
| Distribution of product-based net sales, MEUR and % | 4Q/22 | 3Q/22 | 2Q/22 | 1Q/22 | 4Q/21 |
| Defense & Security products | 15.8 75.5% |
3.1 33.6% |
8.2 51.6% |
7.8 68.2% |
15.5 67.6% |
| Medical Technologies products | 5.1 24.5% |
6.2 66.4% |
7.7 48.4% |
3.6 31.8% |
7.4 32.4% |
| Distribution of service-based net sales, MEUR and % | 4Q/22 | 3Q/22 | 2Q/22 | 1Q/22 | 4Q/21 |
| Connectivity Solutions R&D services | 4.2 62.4% |
3.0 66.4% |
3.7 54.6% |
4.3 60.9% |
4.6 64.8% |
| Other service-based net sales | 2.5 37.6% |
1.5 33.6% |
3.1 45.4% |
2.7 39.1% |
2.5 35.2% |
| Distribution of net sales by market areas, MEUR and % | 4Q/22 | 3Q/22 | 2Q/22 | 1Q/22 | 4Q/21 |
| Asia | 0.5 1.8% |
0.3 1.9% |
0.2 0.9% |
0.3 1.7% |
0.2 0.6% |
| North and South America | 7.6 27.7% |
5.3 38.1% |
6.6 29.1% |
3.8 20.8% |
8.8 29.2% |
| Europe | 19.5 70.6% |
8.3 60.0% |
15.9 70.0% |
14.2 77.4% |
21.1 70.2% |